NASDAQ:PMD

Psychemedics (PMD) Stock Price, News & Analysis

$2.54
-0.10 (-3.79%)
(As of 04/25/2024 ET)
Today's Range
$2.54
$2.64
50-Day Range
$2.54
$3.18
52-Week Range
$2.06
$5.59
Volume
2,997 shs
Average Volume
11,157 shs
Market Capitalization
$14.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PMD stock logo

About Psychemedics Stock (NASDAQ:PMD)

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, Fentanyl, and alcohol. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Dallas, Texas.

PMD Stock Price History

PMD Stock News Headlines

What is the 72-Hour Profit Surge?
One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…
What is the 72-Hour Profit Surge?
One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…
Psychemedics reports Q3 results
Psychemedics Corp PMD
Psychemedics Eliminates Dividend
See More Headlines
Receive PMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Psychemedics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/28/2024
Today
4/25/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical laboratories
Sub-Industry
N/A
Current Symbol
NASDAQ:PMD
Employees
116
Year Founded
1985

Profitability

Net Income
$-4,150,000.00
Pretax Margin
-15.56%

Debt

Sales & Book Value

Annual Sales
$22.10 million
Book Value
$1.15 per share

Miscellaneous

Free Float
4,413,000
Market Cap
$14.76 million
Optionable
Not Optionable
Beta
0.64

Social Links

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Brian Hullinger (Age 56)
    President, CEO & Director
    Comp: $361.37k
  • Ms. Daniella Mehalik (Age 34)
    Vice President of Finance
    Comp: $126.41k
  • Ms. Shannon Shoemaker
    Chief Revenue Officer
  • Dr. Werner A. Baumgartner Ph.D.
    Founder
  • Ms. Annette Baumgartner
    Founder
  • Mr. Michael Weisenhoff (Age 34)
    Principal Financial & Accounting Manager
  • Mr. Patrick J. Kinney Jr.
    Secretary

PMD Stock Analysis - Frequently Asked Questions

How have PMD shares performed in 2024?

Psychemedics' stock was trading at $2.96 at the start of the year. Since then, PMD shares have decreased by 14.2% and is now trading at $2.54.
View the best growth stocks for 2024 here
.

When is Psychemedics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our PMD earnings forecast
.

How were Psychemedics' earnings last quarter?

Psychemedics Co. (NASDAQ:PMD) posted its earnings results on Thursday, March, 28th. The company reported ($0.16) EPS for the quarter. The business earned $5 million during the quarter. Psychemedics had a negative net margin of 18.39% and a negative trailing twelve-month return on equity of 48.68%.

How often does Psychemedics pay dividends? What is the dividend yield for Psychemedics?

Psychemedics declared a quarterly dividend on Tuesday, May 9th. Stockholders of record on Thursday, May 25th will be paid a dividend of $0.07 per share on Thursday, June 8th. This represents a $0.28 annualized dividend and a dividend yield of 11.02%. The ex-dividend date of this dividend is Wednesday, May 24th.
Read our dividend analysis for PMD
.

What is Raymond C. Kubacki Jr.'s approval rating as Psychemedics' CEO?

6 employees have rated Psychemedics Chief Executive Officer Raymond C. Kubacki Jr. on Glassdoor.com. Raymond C. Kubacki Jr. has an approval rating of 67% among the company's employees.

What other stocks do shareholders of Psychemedics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Psychemedics investors own include Zynerba Pharmaceuticals (ZYNE), Dominion Energy (D), Sorrento Therapeutics (SRNE), AT&T (T), AbbVie (ABBV), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pattern Energy Group (PEGI) and Simon Property Group (SPG).

How do I buy shares of Psychemedics?

Shares of PMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PMD) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners